Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Boehringer Ingelheim
McKinsey
McKesson
Colorcon

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087973

See Plans and Pricing

« Back to Dashboard

NDA 087973 describes DISULFIRAM, which is a drug marketed by Alvogen, Chartwell Molecules, Mylan, Par Pharm, Sigmapharm Labs Llc, Watson Labs, Watson Labs Teva, and West-ward Pharms Int, and is included in eleven NDAs. It is available from five suppliers. Additional details are available on the DISULFIRAM profile page.

The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Summary for 087973
Tradename:DISULFIRAM
Applicant:Watson Labs
Ingredient:disulfiram
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087973

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Aug 5, 1983TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Colorcon
Boehringer Ingelheim
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.